Prognostic relevance of Tensin4 expression in human gastric cancer

Katsuya Sakashita, Koshi Mimori, Fumiaki Tanaka, Yukio Kamohara, Hiroshi Inoue, Tetsuji Sawada, Kosei Hirakawa, Masaki Mori

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: The Tensin4 gene is involved in various biological events by mediating signal transduction. This study was designed to clarify its clinical significance in gastric cancer. Methods: A total of 114 gastric cancer patients were enrolled in this study, and we obtained paired samples from tumor tissue and matched normal mucosa. Total RNA was extracted, and TNS4 mRNA expression was quantified using real-time reverse-transcription polymerase chain reaction. TNS4 protein expression was investigated by immunohistochemistry. Additionally, the relationship between TNS4 expression and clinicopathologic factors was statistically analyzed. Results: TNS4 mRNA expression was significantly higher in tumor tissue than in normal mucosa (p < 0.0001). Additional immunohistochemical analysis demonstrated that TNS4 protein was predominantly expressed in gastric cancer. Tumors with higher TNS4 mRNA expression showed histologically poorer grade (p < 0.02), deeper invasion into the serosa (p < 0.01), more positive lymph node metastasis (p < 0.02) or peritoneal dissemination (p < 0.05). Patients with high TNS4 mRNA expression tumor were more likely to have cancer-related death (p < 0.05). A Kaplan-Meier curve also demonstrated that patients with high TNS4 expression tumor had significantly poorer prognosis (p < 0.01) than those with low TNS4 expression tumor. In particular, the 2-year overall survival rates were 48.2% and 83.1%, respectively, a very significant difference. Multivariate analysis revealed that high TNS4 mRNA expression was an independent prognostic predictor (relative risk 1.41, 95% confidence interval 1.03-1.96, p = 0.03). Conclusion: TNS4 was frequently overexpressed in gastric cancer, and tumors with high TNS4 mRNA expression showed biologically aggressive behavior. High TNS4 mRNA expression may be a novel prognostic predictor for those patients.

Original languageEnglish
Pages (from-to)2606-2613
Number of pages8
JournalAnnals of Surgical Oncology
Volume15
Issue number9
DOIs
Publication statusPublished - Sep 1 2008

Fingerprint

Stomach Neoplasms
Messenger RNA
Neoplasms
Mucous Membrane
Serous Membrane
Reverse Transcription
Signal Transduction
Proteins
Multivariate Analysis
Survival Rate
Lymph Nodes
Immunohistochemistry
RNA
Confidence Intervals
Neoplasm Metastasis
Polymerase Chain Reaction
Genes

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Prognostic relevance of Tensin4 expression in human gastric cancer. / Sakashita, Katsuya; Mimori, Koshi; Tanaka, Fumiaki; Kamohara, Yukio; Inoue, Hiroshi; Sawada, Tetsuji; Hirakawa, Kosei; Mori, Masaki.

In: Annals of Surgical Oncology, Vol. 15, No. 9, 01.09.2008, p. 2606-2613.

Research output: Contribution to journalArticle

Sakashita, K, Mimori, K, Tanaka, F, Kamohara, Y, Inoue, H, Sawada, T, Hirakawa, K & Mori, M 2008, 'Prognostic relevance of Tensin4 expression in human gastric cancer', Annals of Surgical Oncology, vol. 15, no. 9, pp. 2606-2613. https://doi.org/10.1245/s10434-008-9989-8
Sakashita, Katsuya ; Mimori, Koshi ; Tanaka, Fumiaki ; Kamohara, Yukio ; Inoue, Hiroshi ; Sawada, Tetsuji ; Hirakawa, Kosei ; Mori, Masaki. / Prognostic relevance of Tensin4 expression in human gastric cancer. In: Annals of Surgical Oncology. 2008 ; Vol. 15, No. 9. pp. 2606-2613.
@article{9abc8e31871040d9818440b3a37947f9,
title = "Prognostic relevance of Tensin4 expression in human gastric cancer",
abstract = "Background: The Tensin4 gene is involved in various biological events by mediating signal transduction. This study was designed to clarify its clinical significance in gastric cancer. Methods: A total of 114 gastric cancer patients were enrolled in this study, and we obtained paired samples from tumor tissue and matched normal mucosa. Total RNA was extracted, and TNS4 mRNA expression was quantified using real-time reverse-transcription polymerase chain reaction. TNS4 protein expression was investigated by immunohistochemistry. Additionally, the relationship between TNS4 expression and clinicopathologic factors was statistically analyzed. Results: TNS4 mRNA expression was significantly higher in tumor tissue than in normal mucosa (p < 0.0001). Additional immunohistochemical analysis demonstrated that TNS4 protein was predominantly expressed in gastric cancer. Tumors with higher TNS4 mRNA expression showed histologically poorer grade (p < 0.02), deeper invasion into the serosa (p < 0.01), more positive lymph node metastasis (p < 0.02) or peritoneal dissemination (p < 0.05). Patients with high TNS4 mRNA expression tumor were more likely to have cancer-related death (p < 0.05). A Kaplan-Meier curve also demonstrated that patients with high TNS4 expression tumor had significantly poorer prognosis (p < 0.01) than those with low TNS4 expression tumor. In particular, the 2-year overall survival rates were 48.2{\%} and 83.1{\%}, respectively, a very significant difference. Multivariate analysis revealed that high TNS4 mRNA expression was an independent prognostic predictor (relative risk 1.41, 95{\%} confidence interval 1.03-1.96, p = 0.03). Conclusion: TNS4 was frequently overexpressed in gastric cancer, and tumors with high TNS4 mRNA expression showed biologically aggressive behavior. High TNS4 mRNA expression may be a novel prognostic predictor for those patients.",
author = "Katsuya Sakashita and Koshi Mimori and Fumiaki Tanaka and Yukio Kamohara and Hiroshi Inoue and Tetsuji Sawada and Kosei Hirakawa and Masaki Mori",
year = "2008",
month = "9",
day = "1",
doi = "10.1245/s10434-008-9989-8",
language = "English",
volume = "15",
pages = "2606--2613",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Prognostic relevance of Tensin4 expression in human gastric cancer

AU - Sakashita, Katsuya

AU - Mimori, Koshi

AU - Tanaka, Fumiaki

AU - Kamohara, Yukio

AU - Inoue, Hiroshi

AU - Sawada, Tetsuji

AU - Hirakawa, Kosei

AU - Mori, Masaki

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Background: The Tensin4 gene is involved in various biological events by mediating signal transduction. This study was designed to clarify its clinical significance in gastric cancer. Methods: A total of 114 gastric cancer patients were enrolled in this study, and we obtained paired samples from tumor tissue and matched normal mucosa. Total RNA was extracted, and TNS4 mRNA expression was quantified using real-time reverse-transcription polymerase chain reaction. TNS4 protein expression was investigated by immunohistochemistry. Additionally, the relationship between TNS4 expression and clinicopathologic factors was statistically analyzed. Results: TNS4 mRNA expression was significantly higher in tumor tissue than in normal mucosa (p < 0.0001). Additional immunohistochemical analysis demonstrated that TNS4 protein was predominantly expressed in gastric cancer. Tumors with higher TNS4 mRNA expression showed histologically poorer grade (p < 0.02), deeper invasion into the serosa (p < 0.01), more positive lymph node metastasis (p < 0.02) or peritoneal dissemination (p < 0.05). Patients with high TNS4 mRNA expression tumor were more likely to have cancer-related death (p < 0.05). A Kaplan-Meier curve also demonstrated that patients with high TNS4 expression tumor had significantly poorer prognosis (p < 0.01) than those with low TNS4 expression tumor. In particular, the 2-year overall survival rates were 48.2% and 83.1%, respectively, a very significant difference. Multivariate analysis revealed that high TNS4 mRNA expression was an independent prognostic predictor (relative risk 1.41, 95% confidence interval 1.03-1.96, p = 0.03). Conclusion: TNS4 was frequently overexpressed in gastric cancer, and tumors with high TNS4 mRNA expression showed biologically aggressive behavior. High TNS4 mRNA expression may be a novel prognostic predictor for those patients.

AB - Background: The Tensin4 gene is involved in various biological events by mediating signal transduction. This study was designed to clarify its clinical significance in gastric cancer. Methods: A total of 114 gastric cancer patients were enrolled in this study, and we obtained paired samples from tumor tissue and matched normal mucosa. Total RNA was extracted, and TNS4 mRNA expression was quantified using real-time reverse-transcription polymerase chain reaction. TNS4 protein expression was investigated by immunohistochemistry. Additionally, the relationship between TNS4 expression and clinicopathologic factors was statistically analyzed. Results: TNS4 mRNA expression was significantly higher in tumor tissue than in normal mucosa (p < 0.0001). Additional immunohistochemical analysis demonstrated that TNS4 protein was predominantly expressed in gastric cancer. Tumors with higher TNS4 mRNA expression showed histologically poorer grade (p < 0.02), deeper invasion into the serosa (p < 0.01), more positive lymph node metastasis (p < 0.02) or peritoneal dissemination (p < 0.05). Patients with high TNS4 mRNA expression tumor were more likely to have cancer-related death (p < 0.05). A Kaplan-Meier curve also demonstrated that patients with high TNS4 expression tumor had significantly poorer prognosis (p < 0.01) than those with low TNS4 expression tumor. In particular, the 2-year overall survival rates were 48.2% and 83.1%, respectively, a very significant difference. Multivariate analysis revealed that high TNS4 mRNA expression was an independent prognostic predictor (relative risk 1.41, 95% confidence interval 1.03-1.96, p = 0.03). Conclusion: TNS4 was frequently overexpressed in gastric cancer, and tumors with high TNS4 mRNA expression showed biologically aggressive behavior. High TNS4 mRNA expression may be a novel prognostic predictor for those patients.

UR - http://www.scopus.com/inward/record.url?scp=50049117459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50049117459&partnerID=8YFLogxK

U2 - 10.1245/s10434-008-9989-8

DO - 10.1245/s10434-008-9989-8

M3 - Article

VL - 15

SP - 2606

EP - 2613

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 9

ER -